1. A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy
- Author
-
Andris Zeltins, Martin F. Bachmann, Federico Storni, Monique Vogel, Gustavo Cabral-Miranda, Paul Engeroff, Elisa S Roesti, Lisha Zha, and Mark S. Cragg
- Subjects
medicine.drug_class ,Immunology ,Peanut allergy ,610 Medicine & health ,medicine.disease_cause ,Monoclonal antibody ,03 medical and health sciences ,0302 clinical medicine ,Allergen ,In vivo ,Food allergy ,medicine ,Immunology and Allergy ,030223 otorhinolaryngology ,Receptor ,biology ,Chemistry ,food and beverages ,General Medicine ,medicine.disease ,030228 respiratory system ,Monoclonal ,biology.protein ,Antibody ,Experimental Allergy – Brief Report - Abstract
Background: Peanut allergy is the most prevalent and dangerous food allergy. Peanuts consist of a large number of different allergens and peanut-allergic patients are frequently sensitized to multiple allergens. Hence, conventional desensitization approaches aim at targeting as many allergens as possible. Methods: The monoclonal anti-Ara h 2 antibody (mAb) was produced by hybridoma cells derived from WT BALB/c mice after immunization with a vaccine based on virus-like particles coupled to Ara h 2. BALB/c mice were sensitized intraperitoneally with peanut extract absorbed to alum and mAbs were applied i.v. Challenge was performed the next day with the whole peanut extract intravenously and via skin prick test. Results: Here we show in peanut-allergic mice that a single high-affinity mAb specific for Ara h 2 is able to block systemic and local allergic reactions induced by the complex peanut extract. We confirm in vitro binding of the mAb to the inhibitory low-affinity FcγRIIb receptor using a sensitive biosensor and demonstrate in vivo that protection was dependent on FcγRIIb. Conclusion: A single mAb specific for Ara h 2 is able to improve local and systemic allergic symptoms induced by the whole allergen mixture.
- Published
- 2020
- Full Text
- View/download PDF